VITANE PHARMA
Gland Pharma buys Vitane’s assets to scale up production of Sputnik VVitane Biologics, with around 100 personnel, has a dedicated research and development facility and a manufacturing plant to handle both mic...
Stock of Indian Sputnik V maker gets a shot in the arm; analysts see long runwayThe company reported 34 per cent growth in consolidated net profit at Rs 260.4 crore for March quarter on robust sales.
Cerestra Advisors may list realty portfolios as REITCerestra is a core assets focused platform building educ infra practise targeted at K-12 Schools with a simple sale & lease back propositio...
- Load More